UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045698 |
|---|---|
| Receipt number | R000052161 |
| Scientific Title | Pneumothorax associated with gastrointestinal perforation: a systematic review |
| Date of disclosure of the study information | 2021/10/08 |
| Last modified on | 2025/11/26 10:29:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Pneumothorax associated with gastrointestinal perforation: a systematic review
Acronym
Pneumothorax associated with gastrointestinal perforation: a systematic review
Scientific Title
Pneumothorax associated with gastrointestinal perforation: a systematic review
Scientific Title:Acronym
Pneumothorax associated with gastrointestinal perforation: a systematic review
Region
| Japan |
Condition
Condition
Pneumothorax associated with gastrointestinal perforation
Classification by specialty
| Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Chest surgery |
| Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To review the clinical features, pathogenesis, diagnosis, and treatment of patients who suffered from pneumothorax associated with gastrointestinal perforation.
Basic objectives2
Others
Basic objectives -Others
To review previous case reports/series on patients who suffered from pneumothorax associated with gastrointestinal perforation, and describe the clinical features, pathogenesis, diagnosis, and treatment of this entity.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prognosis
Key secondary outcomes
1.Site of pneumothorax
2.Severity of pneumothorax
3.Diagnosis
4.Treatment
5.Time from onset to diagnosis
6.Pathogenesis of pneumothorax
7.Complications
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Case reports or series that reported on patients who developed pneumothorax associated with gastrointestinal perforation.
Key exclusion criteria
Case reports or series that were published in non-peer-reviewed Journal.
Case reports or series with pneumothorax that is clearly demonstrated to be not related to gastrointestinal perforation.
Target sample size
0
Research contact person
Name of lead principal investigator
| 1st name | Tomoya |
| Middle name | |
| Last name | Yamaguchi |
Organization
Nara Prefecture General Medical Center
Division name
Division of Critical Care Medicine
Zip code
6308581
Address
2-897-5 Shichijonishimachi, Nara, Nara
TEL
0742-46-6001
coldasister@gmail.com
Public contact
Name of contact person
| 1st name | Tomoya |
| Middle name | |
| Last name | Yamaguchi |
Organization
Nara Prefecture General Medical Center
Division name
Division of Critical Care Medicine
Zip code
6308581
Address
2-897-5 Shichijonishimachi, Nara, Nara
TEL
0742-46-6001
Homepage URL
coldasister@gmail.com
Sponsor or person
Institute
Nara Prefecture General Medical Center
Institute
Department
Personal name
Funding Source
Organization
No funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Nara Prefecture General Medical Center
Address
2-897-5 Shichijonishimachi, Nara, Nara
Tel
0742-46-6001
coldasister@gmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 10 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2021 | Year | 10 | Month | 07 | Day |
Date of IRB
Anticipated trial start date
| 2021 | Year | 10 | Month | 08 | Day |
Last follow-up date
| 2024 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2025 | Year | 02 | Month | 12 | Day |
Date trial data considered complete
| 2025 | Year | 02 | Month | 12 | Day |
Date analysis concluded
| 2026 | Year | 04 | Month | 01 | Day |
Other
Other related information
This study is a systematic review, and the last follow-up date refers to the expected end date of the systematic review.
Management information
Registered date
| 2021 | Year | 10 | Month | 07 | Day |
Last modified on
| 2025 | Year | 11 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052161
